KDR/Flk-1-ASO antisense oligonucleotide (AntiCancer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKDR/Flk-1-ASO antisense oligonucleotide (AntiCancer)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnticancer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRNAture IncAnticancer Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A